Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.

Stadler WM, Hayden A, von der Maase H, Roychowdhury D, Dogliotti L, Seymour L, Kaufmann D, Moore M. Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer. Urol Oncol. 2002 Jul-Aug; 7(4):153-7.

View in: PubMed

collapse authors with profiles